- Home
- PWSC vs GH Comparison
PWSC vs GH Comparison
Compare PWSC & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWSC
- GH
- Stock Information
- Founded
- PWSC 1997
- GH 2011
- Country
- PWSC United States
- GH United States
- Employees
- PWSC N/A
- GH N/A
- Industry
- PWSC Computer Software: Prepackaged Software
- GH Medical Specialities
- Sector
- PWSC Technology
- GH Health Care
- Exchange
- PWSC Nasdaq
- GH Nasdaq
- Market Cap
- PWSC 3.8B
- GH 3.0B
- IPO Year
- PWSC 2021
- GH 2018
- Fundamental
- Price
- PWSC $22.78
- GH $26.25
- Analyst Decision
- PWSC Hold
- GH Strong Buy
- Analyst Count
- PWSC 12
- GH 17
- Target Price
- PWSC $23.80
- GH $39.31
- AVG Volume (30 Days)
- PWSC 1.2M
- GH 2.3M
- Earning Date
- PWSC 11-05-2024
- GH 11-04-2024
- Dividend Yield
- PWSC N/A
- GH N/A
- EPS Growth
- PWSC N/A
- GH N/A
- EPS
- PWSC N/A
- GH N/A
- Revenue
- PWSC $740,860,000.00
- GH $643,810,000.00
- Revenue This Year
- PWSC $15.35
- GH $27.01
- Revenue Next Year
- PWSC $10.44
- GH $18.30
- P/E Ratio
- PWSC N/A
- GH N/A
- Revenue Growth
- PWSC 12.79
- GH 26.20
- 52 Week Low
- PWSC $16.15
- GH $15.81
- 52 Week High
- PWSC $25.16
- GH $37.04
- Technical
- Relative Strength Index (RSI)
- PWSC 70.68
- GH 47.12
- Support Level
- PWSC $22.66
- GH $24.55
- Resistance Level
- PWSC $22.80
- GH $25.87
- Average True Range (ATR)
- PWSC 0.04
- GH 1.13
- MACD
- PWSC -0.01
- GH 0.18
- Stochastic Oscillator
- PWSC 67.86
- GH 69.88
About PWSC PowerSchool Holdings Inc.
PowerSchool Holdings Inc is a provider of cloud-based software to the K-12 education market. Its cloud-based technology platform helps schools and districts efficiently manage state reporting and related compliance, special education, finance, HR, talent, registration, attendance, funding, learning, instruction, grading, college and career readiness, assessments, and analytics in one unified platform. The Company's integrated technology approach streamlines operations aggregates disparate data sets and develops insights using predictive modeling and machine learning. It earns revenue from subscription offerings, perpetual software licenses, maintenance and support services, and professional services.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.